A. Beletsi
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 7
- Economic and Financial Impacts of Cancer 3
- Pharmaceutical Economics and Policy 3
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Konstantinos Avgoustakis (6 shared papers)Z. Panagi (4 shared papers)Dionyssis S. Ithakissios (3 shared papers)Evangelia Livaniou (1 shared paper)Gregory P. Evangelatos (1 shared paper)Pavlos Klepetsanis (2 shared papers)E. Karampli (1 shared paper)Elpida Pavi (1 shared paper)
In The Last Decade
A. Beletsi
15 papers receiving 417 citations
Peers
Comparison fields: 5 of 83
- Pharmaceutical Science 135
- Biomaterials 236
- Molecular Medicine 26
- Surfaces, Coatings and Films 19
- Biomedical Engineering 108
Countries citing papers authored by A. Beletsi
This map shows the geographic impact of A. Beletsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Beletsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Beletsi more than expected).
Fields of papers citing papers by A. Beletsi
This network shows the impact of papers produced by A. Beletsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Beletsi. The network helps show where A. Beletsi may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Beletsi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 166 | |
| 2 | 2005 | 105 | |
| 3 | 1999 | 69 | |
| 4 | 2018 | 26 | |
| 5 | 2005 | 17 | |
| 6 | 2014 | 13 | |
| 7 | 2004 | 11 | |
| 8 | 2021 | 9 | |
| 9 | 2016 | 3 | |
| 10 | 2008 | 3 | |
| 11 | 2019 | 2 | |
| 12 | 2020 | 2 | |
| 13 | 2022 | 1 | |
| 14 | 2015 | 1 | |
| 15 | 2013 | 1 | |
| 16 | 2023 | 0 | |
| 17 | 2022 | 0 |
About A. Beletsi
A. Beletsi is a scholar working on Economics and Econometrics, Biomaterials, Cardiology and Cardiovascular Medicine, Pharmaceutical Science and Surgery, having authored 17 papers that have together received 429 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Economic and Financial Impacts of Cancer (3 papers), Advanced Drug Delivery Systems (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Pharmaceutical Economics and Policy (3 papers), Heart rate and cardiovascular health (3 papers), Graphene and Nanomaterials Applications (2 papers) and Protein purification and stability (2 papers). The work is most often cited by research in Pharmaceutical Science (135 citations), Biomaterials (236 citations), Molecular Medicine (26 citations), Surfaces, Coatings and Films (19 citations) and Biomedical Engineering (108 citations). A. Beletsi has collaborated with scholars based in Greece and France. Frequent co-authors include Konstantinos Avgoustakis, Z. Panagi, Dionyssis S. Ithakissios, Evangelia Livaniou, Gregory P. Evangelatos, Pavlos Klepetsanis, E. Karampli, Elpida Pavi, Leondios Leondiadis and Georgia Kourlaba. Their work appears in journals such as Value in Health, International Journal of Pharmaceutics, Journal of Biomedical Materials Research Part A, BMC Health Services Research and Value in Health Regional Issues.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.